- Aggregate reporting evaluates cumulative safety profiles across hundreds of thousands of patient-years rather than single ICSR cases.
- PBRER (ICH E2C R2) mandates holistic benefit-risk evaluation, replacing legacy PSUR formats for post-authorization drug monitoring.
- Development Safety Update Reports (DSURs) are required annually for investigational drugs active in clinical trial phases.
- Aggregate Safety Specialists command premium salary packages starting at ₹5.5 LPA for entry roles up to ₹16 LPA for senior authors.
1. What is Aggregate Safety Reporting?
Under EMA GVP Module VII and FDA 21 CFR 314.80, periodic safety reports must be submitted on exact Data Lock Point (DLP) anniversaries.
2. PBRER vs PSUR: Key Structural Differences
3. The DSUR Lifecycle in Clinical Trials
4. Skills & Career Roadmap for Aggregate Writers
Master Pharmacovigilance & Drug Safety Cohort at Arzon Global
Build audit-ready proof-of-work in software tools (Oracle Argus, ICD-10-CM, Medidata Rave, eCTD, SAS) with 12 weeks of structured cohort training and cryptographic certificate verification.